Literature DB >> 27075317

Habitual coffee consumption and 24-h blood pressure control in older adults with hypertension.

Esther Lopez-Garcia1, Edilberto Orozco-Arbeláez2, Luz María Leon-Muñoz2, Pilar Guallar-Castillon2, Auxiliadora Graciani2, José Ramón Banegas2, Fernando Rodríguez-Artalejo2.   

Abstract

BACKGROUND & AIMS: In normotensive and hypertensive individuals, blood pressure (BP) rises acutely during a few hours following coffee or caffeine consumption. However, the effect of habitual coffee consumption on BP and BP control is uncertain. The aim of this study was to assess the association of habitual coffee consumption on 24-h BP and BP control among older adults with hypertension.
METHODS: Data were taken from the Seniors-Study on Nutrition and Cardiovascular Risk in Spain (ENRICA), a cross-sectional study conducted in 2012 among 1164 individuals aged ≥63 years. Habitual coffee consumption was assessed with a validated diet history. BP was recorded by 24-h ambulatory monitoring. Ambulatory hypertension was defined as BP ≥ 130/80 mm Hg or being under antihypertensive treatment, and uncontrolled BP was deemed as BP ≥ 130/80 mm Hg among hypertensives. Analyses were performed with linear and logistic regressions adjusted for the main confounders, including diet, time since diagnosis of hypertension and the number of antihypertensive drugs.
RESULTS: Among the 715 hypertensive participants, those consuming ≥3 cups of coffee/day showed higher 24-h systolic BP (beta: 3.25 mm Hg, p value = 0.04) and diastolic BP (beta: 2.24 mm Hg, p value = 0.02) than non-coffee drinkers. Compared to non-coffee drinkers, the odds ratios (95% confidence interval) for uncontrolled BP among those consuming 1, 2, and ≥3 cups of coffee/day were, respectively: 1.95 (1.15-3.30), 1.41 (0.75-2.68), and 2.55 (1.28-5.09); p for trend = 0.05. The association was similar among individuals who were smokers, had excess weight (body mass index ≥25 kg/m2), low adherence to the Mediterranean diet, or hypercholesterolemia. No association was found between coffee consumption and having a non-dipper BP pattern (<10% nocturnal decline in BP) among hypertensives.
CONCLUSION: Habitual coffee consumption was associated with uncontrolled BP in a hypertensive older population.
Copyright © 2016 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

Entities:  

Keywords:  24-h blood pressure; BP control; Coffee; Hypertensive population

Mesh:

Substances:

Year:  2016        PMID: 27075317     DOI: 10.1016/j.clnu.2016.03.021

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  5 in total

1.  High salt diet and caffeine: food for thought.

Authors:  Alexander Staruschenko; Daria V Ilatovskaya; Tengis S Pavlov
Journal:  J Thorac Dis       Date:  2016-10       Impact factor: 2.895

2.  Dietary Polyphenol Intake, but Not the Dietary Total Antioxidant Capacity, Is Inversely Related to Cardiovascular Disease in Postmenopausal Polish Women: Results of WOBASZ and WOBASZ II Studies.

Authors:  Anna M Witkowska; Anna Waśkiewicz; Małgorzata E Zujko; Danuta Szcześniewska; Andrzej Pająk; Urszula Stepaniak; Wojciech Drygas
Journal:  Oxid Med Cell Longev       Date:  2017-06-20       Impact factor: 6.543

3.  Gender differences in factors associated with prehypertension and hypertension in Nepal: A nationwide survey.

Authors:  Kingsley Emwinyore Agho; Uchechukwu L Osuagwu; Osita K Ezeh; Pramesh Raj Ghimire; Stanley Chitekwe; Felix Akpojene Ogbo
Journal:  PLoS One       Date:  2018-09-13       Impact factor: 3.240

4.  Association between lifetime coffee consumption and late life cerebral white matter hyperintensities in cognitively normal elderly individuals.

Authors:  Jeongbin Park; Ji Won Han; Ju Ri Lee; Seonjeong Byun; Seung Wan Suh; Jae Hyoung Kim; Ki Woong Kim
Journal:  Sci Rep       Date:  2020-01-16       Impact factor: 4.379

Review 5.  Coffee and Arterial Hypertension.

Authors:  Stanisław Surma; Suzanne Oparil
Journal:  Curr Hypertens Rep       Date:  2021-08-09       Impact factor: 5.369

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.